PONV Rescue Strategy in PACU: High-Risk Laparoscopy... | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Case Discussion ](https://mdster.com/blog?category=case-discussion) 4. PONV Rescue in a High-Risk Laparoscopy Patient: A PACU Case Discussion [ Case Discussion ](https://mdster.com/blog?category=case-discussion) PONV Rescue in a High-Risk Laparoscopy Patient: A PACU Case Discussion ======================================================================== When prophylaxis fails, physiology and receptor-level thinking keep the airway safe—and the patient satisfied. [ MDster Editorial Team ](https://mdster.com/about) · Feb 07, 2026 · 7 min read · 178 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Anesthesiology ](https://mdster.com/blog?tag=anesthesiology) [ PONV ](https://mdster.com/blog?tag=ponv) [ PACU ](https://mdster.com/blog?tag=pacu) [ Antiemetics ](https://mdster.com/blog?tag=antiemetics) [ TIVA ](https://mdster.com/blog?tag=tiva) [ Quality Improvement ](https://mdster.com/blog?tag=quality-improvement) Share this article Share this post On this page 1. [ Case vignette (what matters, fast) ](#case-vignette-what-matters-fast) 2. [ Risk stratification: Apfel score, then “situational risk” ](#risk-stratification-apfel-score-then-situational-risk) 3. [ PACU nausea: don’t miss non-PONV causes while you treat symptoms ](#pacu-nausea-dont-miss-non-ponv-causes-while-you-treat-symptoms) 4. [ Differential diagnosis and first checks ](#differential-diagnosis-and-first-checks) 5. [ Prophylaxis critique: what would have been “guideline-aligned” for her risk? ](#prophylaxis-critique-what-would-have-been-guideline-aligned-for-her-risk) 6. [ Rescue antiemetics: class-switching and timing (this is where boards live) ](#rescue-antiemetics-class-switching-and-timing-this-is-where-boards-live) 7. [ PDNV: the second wave you should plan for before discharge ](#pdnv-the-second-wave-you-should-plan-for-before-discharge) 8. [ Clinical Application (what I would do in the room) ](#clinical-application-what-i-would-do-in-the-room) 9. [ Key Points for Board Exams ](#key-points-for-board-exams) 10. [ Key Points Summary ](#key-points-summary) 11. [ Conclusion ](#conclusion) On this page 1. [ Case vignette (what matters, fast) ](#case-vignette-what-matters-fast) 2. [ Risk stratification: Apfel score, then “situational risk” ](#risk-stratification-apfel-score-then-situational-risk) 3. [ PACU nausea: don’t miss non-PONV causes while you treat symptoms ](#pacu-nausea-dont-miss-non-ponv-causes-while-you-treat-symptoms) 4. [ Differential diagnosis and first checks ](#differential-diagnosis-and-first-checks) 5. [ Prophylaxis critique: what would have been “guideline-aligned” for her risk? ](#prophylaxis-critique-what-would-have-been-guideline-aligned-for-her-risk) 6. [ Rescue antiemetics: class-switching and timing (this is where boards live) ](#rescue-antiemetics-class-switching-and-timing-this-is-where-boards-live) 7. [ PDNV: the second wave you should plan for before discharge ](#pdnv-the-second-wave-you-should-plan-for-before-discharge) 8. [ Clinical Application (what I would do in the room) ](#clinical-application-what-i-would-do-in-the-room) 9. [ Key Points for Board Exams ](#key-points-for-board-exams) 10. [ Key Points Summary ](#key-points-summary) 11. [ Conclusion ](#conclusion) She’s 30 minutes into PACU, pale and dry heaving hard enough to threaten wound pain and aspiration. The nurse just pushed hydromorphone for a VAS 7/10, and now the patient is begging for “anything that will stop the nausea.” This is the moment where “PONV” is either a routine nuisance—or the start of hypoventilation, inability to protect the airway, delayed discharge, and a patient who remembers your anesthetic for all the wrong reasons. Case vignette (what matters, fast) ---------------------------------- A 32-year-old woman (65 kg) undergoes urgent diagnostic laparoscopy for pelvic pain. She is a **non-smoker**, has **severe motion sickness** and **prior postoperative vomiting**, and receives a volatile-based anesthetic (sevoflurane) with rocuronium infusion. Prophylaxis intraoperatively: **ondansetron 4 mg** and **dexamethasone 4 mg**. Case is 45 minutes, uncomplicated. In PACU, after **hydromorphone 0.5 mg IV**, she develops severe nausea with retching. Vitals: BP 105/60, HR 88, SpO₂ 96% RA. Risk stratification: Apfel score, then “situational risk” --------------------------------------------------------- Her simplified **Apfel score is 4/4**: female sex, non-smoker, history of PONV/motion sickness, and postoperative opioids. That translates to an approximate **80% PONV risk**—before you even add laparoscopy (pneumoperitoneum), urgent/emotional stress, and the fact that volatile exposure is a strong early trigger. The practical point is not the exact percentage; it’s that this patient should have been treated as **high-risk from the start**, meaning you plan for both (1) **baseline risk reduction** and (2) **multi-agent prophylaxis** rather than “two drugs and hope.” Recent consensus guidance (including the **Fifth Consensus Guidelines executive summary published online in November 2025**) continues to emphasize risk-adapted, multimodal prevention and class-switching for rescue. PACU nausea: don’t miss non-PONV causes while you treat symptoms ---------------------------------------------------------------- In real PACU workflows, you can’t afford a long diagnostic pause, but you also can’t afford to reflexively stack antiemetics onto a physiologic problem. I mentally run two threads in parallel: give immediate symptom relief *and* do a rapid physiologic screen. > **Clinical Pearl (PACU nausea triage):** If the patient looks “too sick for routine PONV,” treat nausea but simultaneously rule out **hypotension, hypoxia/hypercarbia, and hypoglycemia**, then ask what changed in the last 5–10 minutes (opioid bolus, movement, orthostasis, bleeding). ### Differential diagnosis and first checks Etiology bucketClues you’ll see in PACUFirst move while you treat nausea**Physiologic instability** (hypotension, hypoxia/hypercarbia, hypoglycemia)diaphoresis, altered mentation, desaturation, rising ETCO₂ if monitored, pallorcheck BP trend, SpO₂/ventilation, consider glucose, treat cause (fluids/vasopressor/O₂/ventilatory support/dextrose)**Medication-triggered** (opioids, reversal agents, antibiotics)temporal link to bolus (here: hydromorphone), pruritus, sedationopioid-sparing analgesia, small incremental dosing, consider naloxone microdoses if oversedated**Surgical/abdominal** (bleeding, vagal stimulus, bowel injury, distention)increasing pain, tachycardia, persistent hypotension, rigid abdomen, shoulder pain out of proportionreassess abdomen, communicate with surgeon early, consider labs/imaging if concerning**True PONV** (high-risk phenotype + emetogenic anesthetic)classic nausea/retching with stable vitals, triggered by motion/vestibular inputclass-switch rescue antiemetic + minimize emetogenic inputs In this case, vitals are relatively stable and the temporal association with hydromorphone is strong—so I treat as **breakthrough PONV/opioid-triggered nausea**, but I still verify oxygenation/ventilation and make sure BP isn’t drifting. Prophylaxis critique: what would have been “guideline-aligned” for her risk? ---------------------------------------------------------------------------- Ondansetron + dexamethasone is reasonable for moderate risk; it’s usually **underpowered** for an Apfel-4 patient having laparoscopy under volatile anesthesia. For high-risk patients, consensus approaches favor **3–4 interventions** spanning different mechanisms *plus* baseline risk reduction (the “don’t pour gasoline on the fire” part). The highest-yield modification would have been to **avoid volatiles** altogether: **propofol TIVA** is consistently associated with lower early PONV. Mechanistically, it’s not magic—it’s largely (1) eliminating volatile/N₂O exposure, (2) propofol’s intrinsic antiemetic effect at clinically relevant concentrations, and (3) enabling a more opioid-sparing plan when paired with multimodal analgesia. If TIVA isn’t feasible, then escalate prophylaxis: add a **third class** (e.g., **droperidol/haloperidol**, **transdermal scopolamine** applied preop, or an **NK1 antagonist** when available/appropriate), and tighten the “baseline” items: minimize perioperative opioids (acetaminophen/NSAID when not contraindicated, local infiltration, TAP block when appropriate), avoid emetogenic swings (adequate hydration, avoid excessive neostigmine dosing, gentle emergence). Rescue antiemetics: class-switching and timing (this is where boards live) -------------------------------------------------------------------------- She has already received a **5-HT3 antagonist** (ondansetron) and **dexamethasone**. With breakthrough symptoms in the early PACU window, repeating ondansetron is rarely the best next move; older consensus guidance explicitly discourages re-dosing the same prophylactic class within about **6 hours**, and modern pathways preserve that logic: **switch receptor targets**. For severe nausea with retching, I want something that hits the **CTZ/area postrema** efficiently—an anatomic site at the floor of the fourth ventricle that is functionally outside the BBB and rich in **dopaminergic (D2), serotonergic (5-HT3), neurokinin (NK1), and opioid** signaling. That’s why dopamine antagonists remain high-yield rescue options. Clinically reasonable rescue options here include: - **Droperidol 0.625–1.25 mg IV** (or low-dose haloperidol per institutional practice), with attention to QT risk, electrolytes, and co-administered QT-prolonging drugs. - **Amisulpride 10 mg IV** (where available) as a D2/D3 antagonist specifically indicated for breakthrough PONV after prophylaxis with a different class. - If you need a fast “bridge” in a tightly monitored setting, a **small propofol bolus** can sometimes blunt symptoms, but it’s not a substitute for definitive rescue and discharge planning. While you’re giving rescue, also remove emetogenic inputs: slow down opioids, add non-opioid analgesics, treat pruritus if present, keep the head elevated, minimize motion, and consider a small fluid bolus if you suspect relative hypovolemia. PDNV: the second wave you should plan for before discharge ---------------------------------------------------------- This patient has multiple features that predict **post-discharge nausea and vomiting**: female sex, younger age, history of PONV/motion sickness, opioid exposure, and now breakthrough nausea in PACU. Discharge readiness is not just “symptoms stopped once.” It’s whether you’ve built a home plan that acknowledges the pharmacology you already used. For discharge, I aim to document (1) what classes were given prophylactically and as rescue, (2) what worked, and (3) what the patient should take at home **from a different or longer-acting strategy** when feasible. The common QI blind spot is measuring only PACU events; tracking **PDNV rate** (via follow-up call/text within 24 hours) better reflects patient burden and helps your service justify protocol changes. Clinical Application (what I would do in the room) -------------------------------------------------- I’d treat her retching as urgent: airway positioning, suction ready, oxygenation/ventilation check, quick BP trend and (if any doubt) glucose. For rescue, I’d **class-switch to a dopamine antagonist** (institution-dependent: droperidol/haloperidol/amisulpride) and simultaneously pivot analgesia to **opioid-sparing** (acetaminophen/NSAID if allowed, consider local/regional options, and smaller incremental opioid dosing). Before discharge, I’d counsel explicitly about recurrence risk, hydration, and when to seek help, and I’d ensure access to an appropriate **home rescue antiemetic plan** rather than relying on “tough it out.” Key Points for Board Exams -------------------------- - **Simplified Apfel score**: 0/1/2/3/4 risk factors ≈ **10/20/40/60/80%** PONV risk; this patient is **4 → ~80%**. - High-risk patients generally warrant **multimodal prophylaxis** (often **3–4** interventions) plus **baseline risk reduction** (especially avoiding volatiles/N₂O and minimizing opioids). - Breakthrough PONV shortly after prophylaxis: **don’t repeat the same class early**; **switch classes** for rescue. - The **CTZ/area postrema** is a prime target for rescue because it’s effectively outside the BBB and rich in D2/5-HT3/NK1 signaling. - **PDNV** matters: plan for it, measure it, and discharge with a strategy that reflects what already failed in PACU. Key Points Summary ------------------ - This patient’s prophylaxis was likely insufficient for her risk phenotype. - In PACU, treat symptoms immediately, but rapidly exclude hypoxia/ventilatory failure, hypotension, and other non-PONV causes. - Rescue therapy should target **a different receptor class** than prophylaxis and be paired with opioid-sparing analgesia. - Build a discharge plan that anticipates **PDNV**, not just PACU stability. Conclusion ---------- Breakthrough PONV in a high-risk laparoscopy patient is rarely “bad luck.” It’s usually the predictable intersection of phenotype (motion sickness/PONV history), emetogenic anesthetic choices (volatile + opioids), and under-escalated prophylaxis. When it happens anyway, the safest PACU posture is parallel processing: stabilize physiology, class-switch rescue therapy with CTZ-level intent, and discharge with a plan that acknowledges the very high probability of recurrence outside your unit. Study pathway Build momentum in Anesthesiology with focused, exam‑style practice -------------------------------------------------------------------- - Airway, ventilation, and crisis drills - High‑yield anesthesia pharmacology made practical - Track weak topics and improve faster Free 5-day trial No credit card required. [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Anesthesiology ](https://mdster.com/blog?tag=anesthesiology) [ # PONV ](https://mdster.com/blog?tag=ponv) [ # PACU ](https://mdster.com/blog?tag=pacu) [ # Antiemetics ](https://mdster.com/blog?tag=antiemetics) [ # TIVA ](https://mdster.com/blog?tag=tiva) [ # Quality Improvement ](https://mdster.com/blog?tag=quality-improvement) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Case Discussion ----------------------- [ See all ](https://mdster.com/blog?category=case-discussion) [### Redo CABG Anesthesia: Managing Catastrophic RV Reentry Injury 5 min read Aug 19, 2026 ](https://mdster.com/blog/redo-cabg-anesthesia-managing-catastrophic-rv-reentry-injury) [### Acute Psychosis and Violence Risk: A Psychiatry Case Discussion 5 min read Aug 17, 2026 ](https://mdster.com/blog/acute-psychosis-and-violence-risk-a-psychiatry-case-discussion) [### HPV Self-Collection in Primary Care: Cervical Screening Case 5 min read Aug 15, 2026 ](https://mdster.com/blog/hpv-self-collection-in-primary-care-cervical-screening-case) Related Posts ------------- [ ![Redo CABG Anesthesia: Managing Catastrophic RV Reentry Injury](https://mdster.com/storage/blog/images/redo-cabg-anesthesia-managing-catastrophic-rv-reentry-injury.jpg) Case Discussion ### Redo CABG Anesthesia: Managing Catastrophic RV Reentry Injury A case discussion on redo CABG anesthesia, CT-defined reentry risk, catastrophic RV laceration, emergency CPB, coagulopathy, and stroke prevention. 5 min read 0 comments ](https://mdster.com/blog/redo-cabg-anesthesia-managing-catastrophic-rv-reentry-injury) [ ![Acute Psychosis and Violence Risk: A Psychiatry Case Discussion](https://mdster.com/storage/blog/images/acute-psychosis-and-violence-risk-a-psychiatry-case-discussion.jpg) Case Discussion ### Acute Psychosis and Violence Risk: A Psychiatry Case Discussion A board-focused case discussion covering stimulant-associated agitation, rapid tranquillisation, targeted violence risk, legal duties, and long-term prevention. 5 min read 0 comments ](https://mdster.com/blog/acute-psychosis-and-violence-risk-a-psychiatry-case-discussion) [ ![Epidural Complications and Troubleshooting: A Clinical Guide](https://mdster.com/storage/blog/images/epidural-complications-and-troubleshooting-a-clinical-guide.jpg) Medical Education ### Epidural Complications and Troubleshooting: A Clinical Guide Learn to distinguish epidural failure from emergencies, recognize catheter migration, and systematically rescue patchy or unilateral neuraxial blockade. 5 min read 0 comments ](https://mdster.com/blog/epidural-complications-and-troubleshooting-a-clinical-guide) [ ![HPV Self-Collection in Primary Care: Cervical Screening Case](https://mdster.com/storage/blog/images/hpv-self-collection-in-primary-care-cervical-screening-case.jpg) Case Discussion ### HPV Self-Collection in Primary Care: Cervical Screening Case This case review examines HPV self-collection, screening exclusions, management of HPV16 positivity, painful speculum examinations, and outreach to underscreened patients. 5 min read 0 comments ](https://mdster.com/blog/hpv-self-collection-in-primary-care-cervical-screening-case) [ ![Adolescent Anorexia Nervosa: Admission and Refeeding Case](https://mdster.com/storage/blog/images/adolescent-anorexia-nervosa-admission-and-refeeding-case.jpg) Case Discussion ### Adolescent Anorexia Nervosa: Admission and Refeeding Case A board-focused case discussion covering hospitalization criteria, refeeding syndrome, phosphate replacement, family-based treatment, and safe return to sport. 5 min read 0 comments ](https://mdster.com/blog/adolescent-anorexia-nervosa-admission-and-refeeding-case) [ ![How to Pass the Fellowship of the College of Anaesthetists of South Africa (Part II)](https://mdster.com/storage/blog/images/how-to-pass-the-fellowship-of-the-college-of-anaesthetists-of-south-africa-part-ii.jpg) Study Tips ### How to Pass the Fellowship of the College of Anaesthetists of South Africa (Part II) A practical FCA(SA) Part II plan covering SBA pacing, SAQ structure, data-interpretation drills, OSCE practice, resources and avoidable errors. 5 min read 0 comments ](https://mdster.com/blog/how-to-pass-the-fellowship-of-the-college-of-anaesthetists-of-south-africa-part-ii) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ Download on the App Store ](https://apps.apple.com/app/id6759168258) [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://apps.apple.com/app/id6759168258) [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept